Does INTERFERON BETA-1B Cause Neoplasm malignant? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Neoplasm malignant have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 0.2% of all adverse event reports for INTERFERON BETA-1B.
23
Reports of Neoplasm malignant with INTERFERON BETA-1B
0.2%
of all INTERFERON BETA-1B reports
7
Deaths
5
Hospitalizations
How Dangerous Is Neoplasm malignant From INTERFERON BETA-1B?
Of the 23 reports, 7 (30.4%) resulted in death, 5 (21.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1B. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which INTERFERON BETA-1B Alternatives Have Lower Neoplasm malignant Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS